Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study

dc.creatorPerez-Mazliah, D E
dc.creatorAlvarez, M G
dc.creatorCooley, G
dc.creatorLococo, B E
dc.creatorBertocchi, Graciela Luciana
dc.creatorPetti, M
dc.creatorAlbareda, María Cecilia
dc.creatorArmenti, A H
dc.creatorTarleton, R L
dc.creatorLaucella, Susana A.
dc.creatorViotti, Rodolfo
dc.date2019-12-05T19:01:33Z
dc.date2019-12-05T19:01:33Z
dc.date2013-02
dc.date.accessioned2023-08-29T20:06:27Z
dc.date.available2023-08-29T20:06:27Z
dc.identifierhttp://sgc.anlis.gob.ar/handle/123456789/1449
dc.identifier10.1093/jac/dks390
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8519152
dc.descriptionEven though the use of combined drugs has been proved to be effective in other chronic infections, assessment of combined treatment of antiparasitic drugs in human Chagas' disease has not been performed. Herein, a pilot study was conducted to evaluate the tolerance and side effects of a sequential combined treatment of two antiparasitic drugs, allopurinol and benznidazole, in the chronic phase of Trypanosoma cruzi infection.
dc.languageen
dc.relationThe Journal of antimicrobial chemotherapy
dc.rightsopen
dc.titleSequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study
dc.typeArtículo


Este ítem pertenece a la siguiente institución